Bulletin
Prophylactic hyperthermic intraperitoneal chemotherapy in gastric cancer
Gastric cancer is an aggressive malignancy with poor overall survival rates as a result, in part, of its predilection for peritoneal dissemination. Peritoneal metastasis (PM) is found in up to 55 to 60 percent of patients at the time of diagnosis by imaging or staging laparoscopy.1,2 In addition, despite multimodality therapy, peritoneal recurrence occurs in […]
Jennifer A. Yonkus, MD, Rebecca A. Snyder, MD, MPH, Judy C. Boughey, MD, FACS, Travis E. Grotz, MD
January 8, 2021